Tech Company Financing Transactions
Somnus Therapeutics Funding Round
Somnus Therapeutics closed a $15 million Series A funding round on 2/11/2010. Investors included Care Capital and private investors.
Transaction Overview
Company Name
Announced On
2/11/2010
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Care Capital (David Ramsay)
Proceeds Purpose
The additional infusion of capital will support our SKP-1041 Phase 2 trial, which we believe is progressing well; we anticipate disclosing Phase 2 clinical data in appropriate peer-reviewed forums in 2011. In recognition of the participation of CTI Life Sciences, Jean-François Leprince will become a member of the Somnus board of directors, effective immediately.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
135 US Hwy. 202 9
Bedminster, NJ 07921
USA
Bedminster, NJ 07921
USA
Phone
Website
Email Address
Overview
Somnus Therapeutics, Inc. is a private drug development company formed by Care Capital LLC. The company is developing an improved therapeutic to address the top need of insomnia patients: preventing mid-night awakenings without next-day hangovers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gary Cupit
Chief Financial Officer
Daniel Cabo
Chief Medical Officer
Mary Osbakken
VP - Operations
Len Rosenberg
VP - Regulatory Affairs
Christine Blumhardt
Browse more venture capital transactions:
Prev: 2/10/2010: Moodlerooms venture capital transaction
Next: 2/11/2010: Tempronics venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs